Varicella-Zoster Virus Prophylaxis with Low-Dose Acyclovir in Patient with Multiple Myeloma Treated with Bortezomib

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F65269705%3A_____%2F09%3A%230000152" target="_blank" >RIV/65269705:_____/09:#0000152 - isvavai.cz</a>
Alternative codes found
RIV/65269705:_____/09:#0000795
Result on the web
—
DOI - Digital Object Identifier
—

Result language
angličtina
Original language name
Varicella-Zoster Virus Prophylaxis with Low-Dose Acyclovir in Patient with Multiple Myeloma Treated with Bortezomib
Original language description
A total of 11 patients treated with bortezomib did not have nay VZV prophylaxis, and 4 of these 11 patients (36%) developed VZV reactivation in the form of herpes zoster. No VZV Reactivations were observed in the 32 patients who received acyclovir 400 mg3 times daily or the 55 patients who received acyclovir in a dose reduced to 400 mg once daily during bortezomib treatment.
Czech name
Varicella-Zoster Virus Prophylaxis with Low-Dose Acyclovir in Patient with Multiple Myeloma Treated with Bortezomib
Czech description
A total of 11 patients treated with bortezomib did not have nay VZV prophylaxis, and 4 of these 11 patients (36%) developed VZV reactivation in the form of herpes zoster. No VZV Reactivations were observed in the 32 patients who received acyclovir 400 mg3 times daily or the 55 patients who received acyclovir in a dose reduced to 400 mg once daily during bortezomib treatment.

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—

Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year
2009
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)